MEDICLINIC INTERNATIONAL LIMITED - Results of annual general meeting

Results of annual general meeting

Mediclinic International Limited
Incorporated in the Republic of South Africa
Reg. no. 1983/010725/06
Income tax no: 9950122714
JSE Share code: MDC
NSX share code: MCI
ISIN code: ZAE000074142
(“Mediclinic” or “the Company”)

RESULTS OF ANNUAL GENERAL MEETING

Shareholders are advised that at the thirty-second Annual General Meeting
of Mediclinic held today, 23 July 2015, all the ordinary and special
resolutions proposed at the meeting were approved by the requisite
majority of votes, as set out below.

Resolutions           Votes exercised       Total       Shares       Shares
                     (as a percentage   number of        voted    abstained
                         of the total      shares        (as a        (as a
                     number of shares       voted   percentage   percentage
                               voted)                   of the       of the
                        For   Against                    total        total
                                                        issued       issued
                                                         share        share
                                                      capital)     capital)

ORDINARY
RESOLUTIONS:
1. Consideration      99.99%    0.01%     741 785       85.46%        0.11%
of annual                                     741
financial
statements
2. Re-appointment     99.97%    0.03%     741 925       85.48%        0.09%
of external                                   441
auditor
3. Re-election of
directors:
3.1 RE Leu            99.98%    0.02%     741 016       85.37%        0.20%
                                              841
3.2 N Mandela         99.98%    0.02%     741 016       85.37%        0.20%
                                              841
3.3 DK Smith          99.83%    0.17%   740 935 1       85.37%        0.21%
                                               61
3.4 PJ Uys            99.07%    0.93%   738 218 5       85.05%        0.19%
                                               93
4. Re-election of
independent Audit
and Risk Committee
members:
4.1 DK Smith          99.86%    0.14%   740 935 1       85.37%        0.21%
                                               61
4.2 JA Grieve         100.00    0.00%   741 016 8       85.37%        0.20%
                           %                   41
4.3 TD Petersen       99.99%    0.01%   741 016 8       85.37%        0.20%
                                               41
4.4 AA Raath          90.82%    9.18%   741 016 8       85.37%        0.20%
                                               41
5. Non-binding        96.80%    3.20%   741 016 8     85.37%       0.20%
advisory vote on                               41
Group Remuneration
Policy
6. General            85.79%   14.21%   741 925 4     85.48%       0.09%
authority to place                             41
shares under
control of the
directors
7. General            96.95%    3.05%   728 787 0     83.97%       0.09%
authority to issue                             63
shares for cash
SPECIAL
RESOLUTIONS:
1. Approval of        99.94%    0.06%   740 844 1     85.35%       0.21%
non-executive                                  44
directors'
remuneration –
2015/2016
2. General            97.14%    2.86%   727 877 0     83.86%       0.20%
authority to                                   10
repurchase shares
3. General            99.37%    0.63%   741 925 4     85.48%       0.09%
authority to                                   94
provide financial
assistance to
related and inter-
related companies
and corporations

Stellenbosch
23 July 2015

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316 (if dialling from South Africa) or
ethics@mediclinic.com
Website: www.mediclinic.com

Sponsor
South Africa: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Namibia: Simonis Storm Securities (Proprietary) Limited




                                    2

Date: 23/07/2015 04:25:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.